NewsLetterTree.com » is there

News & Views: Anti-Obama Anger; a Microbicide That May Actually Work; Mark King (Fabulously) in Vienna; and More

NewsletterTree.com Staff — Thu, 22 Jul 2010 20:13:51 +0000

If you have trouble reading this e-mail, you can see the online version at: www.thebody.com/updates.html

July 22, 2010

Top Stories at TheBody.com

News & Views Library

HIV News & Views
HIV Transmission

On the Personal Side
HIV Treatment & Health Issues

HIV NEWS & VIEWS

TheBody.com is on the scene at the XVIII International AIDS Conference (AIDS 2010) in Vienna, Austria. We're here bringing you highlights, blog entries, videos, interviews and much more -- as well as a daily rundown of underreported stories and the latest buzz from bloggers, Twitterers and other personalities on the Web. It's all available from our AIDS 2010 home page -- stop by and take a look!

Protesters Open AIDS 2010 With Venom Toward U.S. and President Obama
With a special rancor reserved for the U.S. and President Barack Obama, hundreds of HIV/AIDS activists and people living with HIV marched en masse through Vienna's Messe Wien conference center at the start of AIDS 2010, demanding more money for AIDS funding.

How Much Slack Should Activists Give Obama? Thoughts on Bill Clinton's Speech at AIDS 2010
"Day two of the International AIDS Conference of 2010 began with a bang: an address at the opening plenary by former president Bill Clinton," writes HIV advocate Gary Bell. "I acknowledge that my respect for Bill Clinton had dwindled as a result of his tactics in campaigning for his wife Hillary against [Barack] Obama. Therefore, I was even more pleased to hear his common sense defense of President Obama."

Where HIV Care Is Rare and Precious, 4,000 May Be About to Lose It
One of the 30,000 people in Vienna for AIDS 2010 is Svetlana Antoniak. The vivid gleam in her eyes is offset by a face that has become drawn from exhaustion and worry. Antoniak looks soulworn, and no wonder: She's the head of one of Eastern Europe's most successful HIV/AIDS clinics. And it may be about to die.

Mark S. King is in Vienna for AIDS 2010, and boy is he fabulous. Check out his video blogs from the conference and experience what it's like to be at the largest HIV meeting on the planet!

HIV TRANSMISSION

Study Finds Microbicide Containing HIV Drug Lowers Infection Risk in Women By 39%
For the first time, a microbicide gel containing an HIV medication has been found to have some protective effect against HIV -- and even more protective effect against genital herpes. Although the findings are only preliminary and the gel faces years of additional study, the gel's success still represents a huge step in the development of an HIV prevention method that puts the receptive partner in control during sex.

HIV/AIDS Vaccine Experts Discuss Hopes and Fears for the Future of Vaccine Development
Before AIDS 2010 had even officially begun, some of the luminaries in the HIV/AIDS vaccine field gathered to talk about how bright and bubbly the future looks for vaccine development. All right, it wasn't quite that simple. In fact, a whiplash-inducing change in the vaccine climate has left the field in a precarious position: There's suddenly a lot of excitement, but apparently not a lot of unified direction.

The Man That AIDS Forgot: Safe-Sex Architect Richard Berkowitz
Blogger Mark S. King discusses the sometimes forgotten and shunned Richard Berkowitz, one of the founding fathers of the "safe sex" concept. King explores Berkowtiz's legacy and the obstacles he faced in the early 1980s when he asserted that the promiscuous lifestyles of some gay men were fueling the HIV/AIDS epidemic.

More Headlines on HIV Transmission:

Q & A With the Researchers Behind the Breakthrough Microbicide (From Black AIDS Institute)

AIDS 2010 Studies, Releases: PMTCT, Treating Children, Male Circumcision; National Prevention Programs; IDUs (From the Henry J. Kaiser Family Foundation)

Bill Gates Maps the Way for More Effective HIV Prevention (From aidsmap.com)

75% of New Yorkers Living With HIV/AIDS Are 40 or Older and More Than a Third Are Over 50 (From the New York City Department of Health and Mental Hygiene)

Treatment Newbie, But Already Been Through Two Regimens -- Need Advice!
(A recent post from the "Living With HIV" board)

I recently started meds, but had bad reactions to my first two regimens, which were Truvada and Sustiva, then Truvada, Reyataz and Norvir. I've had to take a six-week break to build up strength for my new regimen, which will be Isentress, Truvada and Reyataz. Can someone please share their experiences taking these meds?

-- sweetvanilla27

Click here to join this discussion, or to start your own!

To do this, you'll need to register with TheBody.com's bulletin boards if you're a new user. Registration is quick and anonymous (all you need is an e-mail address) -- click here to get started !

ON THE PERSONAL SIDE

Fogcityjohn: Mask, or, Losing Face: My Battle With Lipoatrophy
Three years of PMMA injections restored fogcityjohn's face -- but it's not the face he remembers. "In some ways, my new face is 'better' than the one it replaced," he writes in his latest blog entry. "But while this treatment has masked my illness, it can't restore to me the thing I've lost -- my image of myself."

HIV in Contact Sports: Is There a Risk?
Recently, blogger and soccer enthusiast Robert Breining found himself back on the pitch after a three-year break from the sport. In one of his games, he was fouled and fell hard on his face. He got up to discover that he was bleeding. As educated and reasonable about HIV transmission as Robert is, he couldn't help but start thinking anew about HIV disclosure in sports.

Confessions of a Conference Newbie
"AIDS 2010 has brought me a couple of incredible firsts: It's my first AIDS conference, and it's my first time traveling abroad," writes TheBody.com's site manager, Becky Allen. "Either of those things on its own would be overwhelming, but 'overwhelming' doesn't quite cover it. ... I thought I was prepared. I really, really wasn't."

HIV TREATMENT & HEALTH ISSUES

An Anti-Inflammation Antiretroviral? Meet the CCR5/CCR2 Antagonist TBR-652
When it comes to health problems in people with HIV, inflammation is the flavor of the day. In the case of TBR-652, a CCR5 inhibitor in the earliest stages of testing in humans, that's an awfully good thing. What sets TBR-652 apart from other CCR5 inhibitors -- heck, all other antiretrovirals on the market today -- is that it's also designed specifically to block another receptor, CCR2, that's been tied to inflammation.

Profound Discoveries From Around the World on HIV Controllers and Long-Term Nonprogressors
"In the many years I've been following developments on this field, I've never seen as many abstracts or so many countries contribute ... to the body of knowledge being accumulated on [HIV controllers and long-term nonprogressors]," writes Loreen Willenberg. In a series of blog entries, Willenberg reviews research from AIDS 2010 on the small minority of HIV-positive people who control the virus in as-yet-unexplained ways, without antiretroviral therapy.

More Headlines on HIV Treatment and Health Issues:

Watch Video of Major Conference Speeches and Presentations (From Henry J. Kaiser Family Foundation)

Raltegravir Lovefest, Vienna Edition: AIDS 2010 Studies Explore Various Strategies for Use (From TheBody.com's 'Viral Truth' blog)

HIV/HCV Coinfection Further Increases Risk of Bone Fractures (From AIDSmeds.com)

Worried Your Spam Filter Might Trash Our Mailings?

TheBody.com's e-mail updates are especially prone to being caught up in spam filters, since our newsletters tend to refer frequently to sex, drugs, the human anatomy and so forth.

To make sure you never miss one of our mailings because anti-spam software labeled it as junk mail, add *** to your address book, talk to the person who manages your e-mail security or check your anti-spam program's instructions for more information.

About This E-mail

This e-mail update has been sent to ***.

Want to change your subscription? Click here or send us a message at *** .

Missed an update? Our archive of past updates will keep you in the loop.

Have any other questions or comments, and don't want to send an e-mail? Feel free to snail-mail us at:

TheBody.com's E-Mail Updates
The HealthCentral Network, Inc.
250 West 57th Street
New York, NY 10107


	This Week: Call on Congress to Reform Drug Sentencing to Fight HIV/AIDS Participate in a New Survey on HIV Prevention Strategies Targeting MSM NMAC Asks for Your Help Ending S.B. 1070; Promoting Comprehensive Federal Immigration Reform Action Alert: Help Homeless AIDS Activist Get Into Housing Today Action Alert: Urge Your Senator to Support an Extension of Critical Medicaid Funding

Is There A Way Through This Meat Grinder Market?

NewsletterTree.com Staff — Wed, 21 Jul 2010 16:48:37 +0000

Click to view this email in a browser

Dear Reader,

Here we are 7 months into 2010, and the stock market is still in negative territory and just when you think there is a light at the end of the tunnel, it turns out to be an oncoming train.

One commentator I heard the other day described the stock market as a "meat grinder", I can see his point. If you were just an average investor you would definitely feel that way. After a very rough 2008, and encouraging latter part of 2009 and a very tiresome 2010, investors have every right to feel discouraged.

However, many investors, unfortunately, play "victim" at times like these. They make 2 major mistakes.

The first thing they do wrong is buy the "wrong stocks". Just because a company was good in 2007, doesn't necessarily mean it's good today. Yes, it might be a big company, and you feel safe with having shares in it, but it keeps going down doesn't it, or at best, won't go up. These days, you have to think a little "outside the square". You have to recognise things have changed in the last 2 years and they may not return to the way they were for a few more years. The Global Financial Crisis changed all the rules and its pointless sitting on the sidelines waiting for things to improve. By the time they do, the opportunity you have, will have passed.

The second mistake they make, is they wait for good news. They sit on their hands when the share market slumps, and only jump in and buy when the market is going up. Of course, then it goes down again. Hence, the term "meat grinder". Average investors are buying high, and selling low in a panic when the news "turns" the next day.

It's understandable for people to do this. They only want to spend money on shares when they feel good about the decision. However, this is "emotional investing". You feel good when the market's going up, and you get a rush of blood to the head and you think the good news is here to stay - you leap in and buy, often the wrong stocks! This is a mistake.

The only way to make money in a "meat grinder" market is to:

1. Only buy stocks when they are cheap and the market is having a bad day.

2. Never chase a stock. Always set strict limits on how much you'll pay.

3. Don't buy a stock based on past "glories". Buy a stock based on what the future holds. Do your research properly and think about the future, not the past. Investing with history as your guide is like driving a car looking through the rear view mirror. Some stocks do go up in markets like these. The average Trident Confidential stock is up over 20% in the last several months.

4. Always have a strict exit strategy that is in place. Don't let small losses turn into big ones - ever!

Follow these rules and you'll not only survive the "meat grinder" market - you'll prosper. As Warren Buffett says, "Be greedy when others are fearful, and fearful when others are greedy".

Nothing said has ever been more true when it comes to the stock market.

The Bottom Line

The Australian market is down around 10% this year and most investors are probably down around the same. Not a happy time to be an investor. However, this year the Trident Confidential portfolio is up over 30%. That's 4 times better than the market performance. How? By just following the 4 rules shown above. Almost every stock in the portfolio is in profit and most have been bought during 2010.

It's possible to make money in any market, if you buy the right stocks at the right time and leave your emotions to one side.

To prove it to you, I'd like to make you a Guarantee.

I will Guarantee that over the next year you'll make money in the stock market if you Join Trident Confidential.

Not only that, I'll also Guarantee to double the market's return. If the market is in negative territory in a year from now, Trident Confidential won't be.

I'll show you:

- What stocks to buy and when
- Exactly what to pay and where to set your trades
- When to sell and how to ensure any losses (if they occur) stay small

The prices we record in our portfolio, are the same prices you'll pay if you follow our simple rules. It's very simple. All we need is around 30 mins to an hour per week of your time. Of course you'll need some money to invest as well. Many of our subscribers have started with just a few thousand dollars and built up from there. This is not daunting, but it will require a little effort from you and commitment to do something about your financial future.

Join Trident Confidential, and I guarantee that I will show you how to make a profit equal to, or greater than double the market's performance over the next year, and if the market is negative, I guarantee that our portfolio won't be. If I fail, for whatever reason, you won't pay another cent until I make good my guarantee.

Since we started in 2005 our returns have been 148% in 2005, 74% in 2006, 98% in 2007, 23% in 2008, 113% in 2009 and over 30% this year. So, while past performance is not an indication of future performance, our record isn't too bad.

SPECIAL OFFER - In addition to our Profit Guarantee, join us before midnight Monday 26th July and I'll extend your membership by an extra 2 months! Pay for 12, get 14 months of membership.

Click Here to Join Trident Confidential with Our Market Double Profit Guaranteed and Change Your Financial Future

All the excuses people use to justify why they don’t subscribe, invest or change their financial future

Day in, day out we have enquiries from people who really want to change their financial circumstances, but for one reason or another don’t do anything. Here is a list of the usual excuses people make for this. At the end of the day, they are all valid but you can see here, we debunk every one of them. There really is no good reason not to take action. So, if you really are seeking a relatively safe and reliable way to make money, take charge and do something – it is the only way anything will ever change for your future.

Click Here to Read the Top 10 Excuses People Give Us... and Our Reply

If you have any questions about Trident Confidential and what we can offer you, please give us a call on (02) 9544 5135

Until next time.

Kind Regards
Lance Spicer
Editor, Trident Confidential - Still...The World's Highest Returning Newsletter since 2005.

Lance Spicer is qualified and licensed to provide investment advice on Managed Investments, Equities and Derivatives.

Trident Investment Management Pty Ltd is an authorised representative (No 339798) of The International Securities and Derivatives Group Pty Limited (ABN 22 103 552 683) holder of Australian Financial Services License (AFSL 227544)

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link:

Trident Investment Management Pty Limited.
PO Box 13
Cronulla 2230 NSW Australia
www.TridentConfidential.com
www.tridentpress.com.au
Phone: +61 2 9544 5135
Fax: +61 2 9544 5691

Trident Investment Management Pty Ltd is an authorised representative (No 339798) of The International Securities and Derivatives Group Pty Limited (ABN 22 103 552 683) holder of Australian Financial Services License (AFSL 227544)

Read the VerticalResponse marketing policy.